Skip to main navigation Skip to search Skip to main content

SBIR: Developing IpY: A Novel Inhibitor for the treatment of ER+ metastatic breast cancer

Project: Research

Project Details

StatusFinished
Effective start/end date07/10/2006/30/21

Funding

  • National Cancer Institute: $15,000.00